Upcoming Rosenberg Dialogue Series Session
Opioids & Addiction: A Public-Health Approach to Change
Saturday, March 30, 2019
11:45 a.m.-12:45 p.m.
H. Mebane Turner Learning Commons, Town Hall
1415 Maryland Ave.
Free and open to the public.
More About the Dialogue
Trend data on overdose deaths and judicial proceedings show the tragedy of the opioid crisis, its blight on rural and urban America and the failure to resolve it. Where initiatives have made a positive difference, they include a bundle of evidence-based public health, criminal justice and policy actions.
Our panel will address the core of a public-health approach to changing the trends in addiction, incarceration and death from opioids. Each panelist will speak for approximately 20 minutes, and identify the main lessons learned from their perspective. A question-and-answer session with the audience will follow.
Alan Lyles , Henry A. Rosenberg Professor of Government, Business & Nonprofit Partnerships, will moderate the discussion.
About the Guest Panelists
Thomas H. Carr is the Executive Director of the Office of National Drug Control Policy’s (ONDCP) Washington/Baltimore High Intensity Drug Trafficking Area (HIDTA) Program, a position he has held since 1994. He also serves as Executive Director of the University of Baltimore’s Center for Drug Policy and Enforcement.
Mr. Carr has designed and implemented more than 150 drug task forces, 18 drug treatment/criminal justice task forces and five drug prevention task forces during the last 23 years. He currently administers 42 drug task forces and a regional intelligence center that supports more than 150 federal, state and local law enforcement agencies in Maryland, Washington, D.C, Virginia, and West Virginia.
As chairperson of the Performance Management Process Committee, Mr. Carr established metrics to measure the efficiency and effectiveness of drug control efforts in the fields of drug law enforcement, criminal intelligence, treatment and prevention for the HIDTA Program. HIDTA’s Performance Management System electronically collects outcome performance data from 28 HIDTAs and shares this information with Congress on an annual basis. He was awarded the ONDCP Director’s Award for his work in performance management.
In response to the nation’s opioid epidemic, Mr. Carr is working with nine other HIDTAs and the Office of National Drug Control Policy on the Opioid Response Strategy (ORS). This strategy resulted in the creation of a public health-public safety partnership supported by the Centers for Disease Control and Prevention, and the hiring of 24 drug intelligence officers and 24 public health analysts. The ORS has led to the interdisciplinary sharing of opioid data between law enforcement and public health agencies.
Mr. Carr spearheaded the development of the ODMAP, a real-time overdose syndromic surveillance system used to identify spikes in fatal and non-fatal overdoses. In July 2017, Mr. Carr and the ODMAP development team received the Special Achievement in GIS award from Esri Corporation.
Mr. Carr is the lead designer for HIDTA’s Case Explorer system. Case Explorer is not only a case management system, but is also an event and target deconfliction system in use nationwide by law enforcement agencies at all levels of government.
In addition, Mr. Carr was an antiterrorism instructor for the U.S. Department of State’s Antiterrorism Assistance Program. He is the principle author of seven terrorism courses dealing with terrorist financing, intermediate and advanced intelligence, task force management, and criminal investigation that are now delivered worldwide.
Prior to accepting his position with the Washington/Baltimore HIDTA, Mr. Carr was a Lt. Colonel with the Maryland State Police and retired as chief of the Bureau of Drug Enforcement. He graduated from Towson University and was first in his class at the Maryland State Police Academy, class of 1971. He attended the FBI National Academy, the DEA Drug Commanders School and the Federal Executive Institute. He served as an adjunct instructor with the University of Maryland from 1993 to 1999.
Jennifer L. Martin, J.D., M.A., is the Deputy Commissioner: Population Health and Disease Prevention at the Baltimore City Health Department. As Deputy Commissioner, she oversees the agency’s two public health clinics; its HIV/AIDS prevention and treatment programs, including the Ryan White program and syringe exchange programs; the overdose response program; the acute and communicable disease monitoring and investigation program; the Non Emergency Medical Transportation program, the public health preparedness program, and performance management and quality improvement for the agency.
She also represents the Health Commissioner at the Maryland Association of County Health Officers and oversee the agency’s Local Health Improvement Council.
Prior to becoming Deputy Commissioner, Ms. Martin served as both the Director and Deputy Director of the Office of Public Health Preparedness and Response overseeing the agency’s biosurveillance and bioterrorism activities, COOP planning, health and medical response planning, and animal protection services planning. She served on a number of planning groups including the Maryland Region III Health and Medical Task Force and the Maryland State PHEP group.
Ms. Martin serves on the Governor’s Emergency Management Advisory Council in Maryland and is a 2007 graduate of the University of Maryland School of Law and a 2013 graduate of the Naval Postgraduate School.
What is the Rosenberg Dialogue Series?
The University of Baltimore's Henry A. Rosenberg Dialogue Series stimulates interactions among the public, private and nonprofit sectors on leading issues.
More a dialogue than a traditional lecture, each series session brings participants together to present a central issue, discuss the participants' assessments of it and explore how public-private and nonprofit partnerships can work together to resolve, advance or otherwise better the central issue.
Coordinated and led by Alan Lyles , Henry A. Rosenberg Professor of Government, Business and Nonprofit Partnerships, sessions include about half an hour for each panelist's presentation, followed by about half an hour for questions and answers.
The Henry A. Rosenberg Dialogue Series is made possible by the generous support of the Henry and Ruth Blaustein Rosenberg Foundation and the University of Baltimore Foundation.